How much funding has Skye Bioscience raised?

Skye Bioscience has raised $153.0M in total funding, most recently a Private Equity round.

Who are Skye Bioscience's investors?

Skye Bioscience's investors include 5AM Ventures, Jerel Davis.

When was Skye Bioscience founded?

Skye Bioscience was founded in 2011.

Where is Skye Bioscience headquartered?

Skye Bioscience is headquartered in San Diego, United States.

What industry is Skye Bioscience in?

Skye Bioscience operates in Biotech, Healthcare.

How many employees does Skye Bioscience have?

Skye Bioscience has 11-50 employees.

Skye Bioscience

San Diego, United States · Founded 2011 · $153.0M raised

Biotech

Healthcare

Headquarters: San Diego
Employees: 11–50
Founded: 2011
Business Model: B2B

Website: skyebioscience.com
Total Funding: $153.0M
Last Round: $40.0M Private EquityJan 2026
Rounds: 5

About

Skye Bioscience (Nasdaq: SKYE) is a clinical-stage biotechnology company focused on modulating the endocannabinoid system to develop new treatments for obesity and comorbid metabolic conditions. Founded in 2011 and based in San Diego, California, the company's mission is to contribute new mechanisms and drugs that build the mosaic of therapeutic approaches needed to serve patients with diverse metabolic needs, led by President and CEO Punit Dhillon.

Summary

Skye Bioscience is a Biotech company based in San Diego, United States, founded in 2011. It has raised $153.0M in total across 5 rounds, most recently a $40.0M Private Equity round in Jan 2026. Investors include 5AM Ventures and Jerel Davis.